(Q72209104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

main subject

multiple drug resistance

1 reference

A S Chong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

P N Markham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

H M Gebel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

S D Bines

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

J S Coon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

133-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01754414

24 October 2019

exact match

0 references

cites work

Resistance of multidrug-resistant lines to natural killer-like cell-mediated cytotoxicity

1 reference

12 December 2020

Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.

1 reference

12 December 2020

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

1 reference

12 December 2020

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

1 reference

12 December 2020

Expression of a multidrug resistance gene in human cancers

1 reference

12 December 2020

Reversal of drug-resistance in multiple myeloma with verapamil.

1 reference

12 December 2020

Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16

1 reference

12 December 2020

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1 reference

12 December 2020

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

12 December 2020

Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene.

1 reference

12 December 2020

Blocking of lymphokine activated killer (LAK) cell mediated cytotoxicity by cell-sized beads bearing tumor cell proteins

1 reference

12 December 2020

Isolation and expression of a complementary DNA that confers multidrug resistance

1 reference

12 December 2020

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

12 December 2020

Multidrug resistance activity in human lymphocytes

1 reference

12 December 2020

Pharmacology of drugs that alter multidrug resistance in cancer

1 reference

12 December 2020

Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection

1 reference

12 December 2020

Interaction of rhodamine 123 with living cells studied by flow cytometry.

1 reference

12 December 2020

Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance

1 reference

12 December 2020

The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein

1 reference

12 December 2020

Isolation and genetic characterization of human KB cell lines resistant to multiple drugs

1 reference

12 December 2020

Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody

1 reference

12 December 2020

P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins.

1 reference

12 December 2020

Biology of natural killer cells

1 reference

12 December 2020

Expression of a multidrug-resistance gene in human tumors and tissues

1 reference

12 December 2020

The biochemistry of P-glycoprotein-mediated multidrug resistance

1 reference

12 December 2020

Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01754414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8093856%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference